CFA
GSK icon

Camarda Financial Advisors’s GSK GSK Stock Holding History

Camarda Financial Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-11
Closed -$1K – 224
2019
Q2 		$1K Sell
11
-387
-97% -$19.4K ﹤0.01% 414
2019
Q1 		$21K Buy
+398
New +$19.9K 0.04% 134
2018
Q1 		– Sell
-1,600
Closed -$71K – 179
2017
Q4 		$71K Hold
1,600
– – 0.09% 101
2017
Q3 		$81K Hold
1,600
– – 0.09% 100
2017
Q2 		$86K Hold
1,600
– – 0.09% 98
2017
Q1 		$84K Hold
1,600
– – 0.08% 100
2016
Q4 		$77K Sell
1,600
-208
-12% -$10.3K 0.05% 110
2016
Q3 		$97K Hold
1,808
– – 0.06% 104
2016
Q2 		$98K Buy
1,808
+208
+13% +$11K 0.06% 110
2016
Q1 		$81K Hold
1,600
– – 0.05% 136
2015
Q4 		$81K Hold
1,600
– – 0.05% 150
2015
Q3 		$77K Hold
1,600
– – 0.05% 106
2015
Q2 		$83K Sell
1,600
-184
-10% -$10.4K 0.05% 106
2015
Q1 		$103K Hold
1,784
– – 0.06% 103
2014
Q4 		$95K Hold
1,784
– – 0.06% 102
2014
Q3 		$103K Buy
1,784
+184
+12% +$11.3K 0.07% 93
2014
Q2 		$107K Sell
1,600
-400
-20% -$27.1K 0.07% 96
2014
Q1 		$134K Buy
+2,000
New +$135K 0.1% 85

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Camarda Financial Advisors's GSK Position: Q3 2019 in Review

Camarda Financial Advisors sold out of GSK (GSK) in Q3 2019, closing a stake of 11 shares — an estimated $1K sold.

Camarda Financial Advisors first reported a position in GSK in Q1 2014 and held it in 18 quarters. The position peaked at $134K in Q1 2014. 805 funds tracked by Wall St. Rank hold GSK as of Q3 2019.

  • Camarda Financial Advisors reported no remaining GSK position as of Q3 2019 after selling out during the quarter.
  • Camarda Financial Advisors sold 11 GSK shares in Q3 2019, an estimated $1K.
  • Camarda Financial Advisors first reported a position in GSK in Q1 2014 and held it in 18 quarters.
  • Camarda Financial Advisors's GSK position peaked at $134K in Q1 2014.
  • 805 funds tracked by Wall St. Rank held GSK as of Q3 2019.

Based on Camarda Financial Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.